CORE
🇺🇦Â
 make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Filters
1 research outputs found
Conversion back to bevacizumab or ranibizumab for recurrent neovascular activity with aflibercept in age-related macular degeneration: a case series
Author
AA Chang
AH Koh
+32Â more
AT Fung
B Bakall
Brown DM Chen E, Mariani A, Major JC, Group SS
C Ehlken
C Simader
CP Yang
DF Martin
DS Grewal
E Smretschnig
F Coscas
F Forooghian
FM Heussen
H Cho
JH Acton
JL Gasperini
JS Heier
JS Heier
M Miura
MS Eghøj
MW Stewart
N Kumar
P Roberts
PJ Rosenfeld
RL Avery
S Binder
S Lazzeri
S Schaal
SD Targum
T Czarnowicki
VY Ho
WM Amoaku
Y Yonekawa
Publication venue
'Springer Science and Business Media LLC'
Publication date
Field of study
Full text link
Crossref
Full text link
